Ptc Therapeutics, Inc. · NASDAQ:PTCT
Wellington Management Group LLP reported a 6.20% stake in Ptc Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 10, 2025
Wellington Management Group LLP reported a 6.20% stake in Ptc Therapeutics, Inc., 4,787,123 shares, as a passive investor on Dec 31, 2024. Filed Feb 10, 2025 (Schedule 13G/A).
- Stake
- 6.20%
- Shares
- 4,787,123
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 6.20% | 4,787,123 |
| Wellington Group Holdings LLP | 6.20% | 4,787,123 |
| Wellington Investment Advisors Holdings LLP | 6.20% | 4,787,123 |
| Wellington Management Company LLP | 6.10% | 4,787,123 |
Source
Related
- Ptc Therapeutics, Inc.
- Wellington Management Group LLP
- Ptc Therapeutics, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Feb 10, 2026
- Form 4 · Schmertzler Michael · Oct 16, 2026
- Form 4 · Boulding Mark Elliott · Oct 13, 2026
- Form 4 · Schmertzler Michael · Oct 9, 2026
- Form 4 · Boulding Mark Elliott · Oct 7, 2026
- Form 4 · Steele Glenn Jr Md Phd · Oct 2, 2026